Income Taxes - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Line Items]
Provision for income taxes	$ 0	$ 0
Net operating loss carryforwards	12,059,019	11,979,869
Research and development and orphan drug credits	$ 8,700,000
Net operating loss carryforwards term	20 years
Net operating loss carryforwards expiration beginning year	2022
Uncertain tax positions, accruals	$ 0	0
Accruals for interest or penalties related to income tax matters	0	$ 0
U.S. Federal and State
Income Tax Disclosure [Line Items]
Net operating loss carryforwards	51,100,000
State
Income Tax Disclosure [Line Items]
Net operating loss carryforwards	1,700,000
Research and development and orphan drug credits	$ 100,000